131 related articles for article (PubMed ID: 12717417)
61. [Effects of antisense human telomerase RNA on growth of human gastric cancer cells].
Zhang F; Zhang X; Fan D; Deng Z; Yan y ; Wu H
Zhonghua Bing Li Xue Za Zhi; 2000 Oct; 29(5):367-9. PubMed ID: 11866938
[TBL] [Abstract][Full Text] [Related]
62. [Effect of antisense oligodeoxynucleotides of RNA component of human telomerase on cisplatin induced apoptosis in K562 cells].
Xiao Y; Zhang H
Di Yi Jun Yi Da Xue Xue Bao; 2003 Feb; 23(2):144-7. PubMed ID: 12581964
[TBL] [Abstract][Full Text] [Related]
63. [Study on induction of leukemic cell apoptosis by antisense oligodeoxynucleotide of human telomerase RNA].
Xie W; Lin M
Zhonghua Xue Ye Xue Za Zhi; 2001 May; 22(5):245-8. PubMed ID: 11877080
[TBL] [Abstract][Full Text] [Related]
64. Human hepatoma cell telomerase activity inhibition and cell cycle modulation by its RNA component antisense oligodeoxyribonucleotides.
Zhang RG; Wang XW; Yuan JH; Xie H
Acta Pharmacol Sin; 2000 Aug; 21(8):742-6. PubMed ID: 11501185
[TBL] [Abstract][Full Text] [Related]
65. Combination of tamoxifen and antisense human telomerase RNA inhibits glioma cell proliferation and anti-apoptosis via suppression of telomerase activity.
Wang Y; Zhou Z; Luo H; Wu Z; Geng J; Miu W; Pu Y; Liu N; You Y; Yang Z
Mol Med Rep; 2010; 3(6):935-40. PubMed ID: 21472336
[TBL] [Abstract][Full Text] [Related]
66. [Telomerase activity inhibition and apoptosis induction of BEL-7404 human hepatoma cells by antisense oligonucleotides to telomerase RNA component].
Zhang RG; Wang XW; Xie H
Shi Yan Sheng Wu Xue Bao; 2001 Sep; 34(3):213-8. PubMed ID: 12549223
[TBL] [Abstract][Full Text] [Related]
67. Treatment of prostate cancer in vitro and in vivo with 2-5A-anti-telomerase RNA component.
Kondo Y; Koga S; Komata T; Kondo S
Oncogene; 2000 Apr; 19(18):2205-11. PubMed ID: 10822370
[TBL] [Abstract][Full Text] [Related]
68. [Inhibition effect of p53 antisense RNA on malignant phenotype of colorectal cancer cells].
Cao J; Teng L; Cai X
Zhonghua Zhong Liu Za Zhi; 1997 Mar; 19(2):123-6. PubMed ID: 10743076
[TBL] [Abstract][Full Text] [Related]
69. Attenuation of telomerase activity by hammerhead ribozyme targeting human telomerase RNA induces growth retardation and apoptosis in human breast tumor cells.
Yeo M; Rha SY; Jeung HC; Hu SX; Yang SH; Kim YS; An SW; Chung HC
Int J Cancer; 2005 Apr; 114(3):484-9. PubMed ID: 15551309
[TBL] [Abstract][Full Text] [Related]
70. Antisense hTERT inhibits thyroid cancer cell growth.
Teng L; Specht MC; Barden CB; Fahey TJ
J Clin Endocrinol Metab; 2003 Mar; 88(3):1362-6. PubMed ID: 12629130
[TBL] [Abstract][Full Text] [Related]
71. Human telomerase RNA degradation by 2'-5'-linked oligoadenylate antisense chimeras in a cell-free system, cultured tumor cells, and murine xenograft models.
Paranjape JM; Xu D; Kushner DM; Okicki J; Lindner DJ; Cramer H; Silverman RH; Leaman DW
Oligonucleotides; 2006; 16(3):225-38. PubMed ID: 16978086
[TBL] [Abstract][Full Text] [Related]
72. The retrovirus-mediated antisense human telomerase RNA (hTR) gene limits the growth of hepatocellular carcinoma growth in cell culture and animals.
Liu JY; Zhu Q; Li J; Zhao S; Li L
Dig Dis Sci; 2008 Apr; 53(4):1122-30. PubMed ID: 17932748
[TBL] [Abstract][Full Text] [Related]
73. Combined effect of 2-5A-linked antisense against telomerase RNA and conventional therapies on human malignant glioma cells in vitro and in vivo.
Iwado E; Daido S; Kondo Y; Kondo S
Int J Oncol; 2007 Nov; 31(5):1087-95. PubMed ID: 17912434
[TBL] [Abstract][Full Text] [Related]
74. Antisense telomerase RNA inhibits the growth of human glioma cells in vitro and in vivo.
You Y; Pu P; Huang Q; Xia Z; Wang C; Wang G; Yu C; Yu JJ; Reed E; Li QQ
Int J Oncol; 2006 May; 28(5):1225-32. PubMed ID: 16596239
[TBL] [Abstract][Full Text] [Related]
75. [Study on telomerase inhibition by ribozyme targeted to telomerase RNA component].
Qu Y; OuYang X; Liu S; Peng X; Liu B
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Jun; 16(3):133-7. PubMed ID: 10359859
[TBL] [Abstract][Full Text] [Related]
76. Combination therapy of 2-5A antisense against telomerase RNA and cisplatin for malignant gliomas.
Kondo Y; Komata T; Kondo S
Int J Oncol; 2001 Jun; 18(6):1287-92. PubMed ID: 11351264
[TBL] [Abstract][Full Text] [Related]
77. Tackling cancer at the telomeres.
Marx J
Science; 2002 Mar; 295(5564):2350. PubMed ID: 11923505
[No Abstract] [Full Text] [Related]
78. Antitumor effect of a novel adeno-associated virus vector targeting to telomerase activity in tumor cells.
Wang YG; Wang JH; Zhang YH; Gu Q; Liu XY
Acta Biochim Biophys Sin (Shanghai); 2004 Jul; 36(7):492-500. PubMed ID: 15248024
[TBL] [Abstract][Full Text] [Related]
79. Telomerase targeting in cancer treatment: new developments.
Helder MN; Jong S; Vries EG; Zee AG
Drug Resist Updat; 1999 Apr; 2(2):104-115. PubMed ID: 11504478
[TBL] [Abstract][Full Text] [Related]
80. [Expression of antisense telomerase genes suppressing human cancer malignant phenotypes].
Yuan X; Zhang B; Ying J; Wang H; Zhang H; Hou L; Wu B
Zhonghua Bing Li Xue Za Zhi; 1999 Oct; 28(5):356-60. PubMed ID: 11869549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
